TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-253 Cr | ₹319 Cr | ₹30 Cr | ₹-175 Cr | ₹-95 Cr |
What is the latest Net Cash Inflow / Outflow ratio of TORRENT PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-253 Cr |
| Mar2024 | ₹319 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹-175 Cr |
| Mar2021 | ₹-95 Cr |
How is Net Cash Inflow / Outflow of TORRENT PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-253 Cr | Negative | |
| Mar2024 | ₹319 Cr | 955.47 | |
| Mar2023 | ₹30 Cr | Positive | |
| Mar2022 | ₹-175 Cr | Negative | |
| Mar2021 | ₹-95 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹142,437.6 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
| MANKIND PHARMA | ₹82,617.3 Cr | -6.4% | -3% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -4.1% |
-1.2% |
40.3% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses